SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003950
Filing Date
2015-05-11
Accepted
2015-05-11 17:09:38
Documents
13
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20150331.htm 10-Q 1606671
2 EX-10.29 atra-ex1029_20150331368.htm EX-10.29 516085
3 EX-31.1 atra-ex311_201503316.htm EX-31.1 12818
4 EX-31.2 atra-ex312_201503317.htm EX-31.2 12986
5 EX-32.1 atra-ex321_201503318.htm EX-32.1 7484
6 GRAPHIC g201505111918135262298.jpg GRAPHIC 4700
7 GRAPHIC g201505111918179322300.jpg GRAPHIC 3932
  Complete submission text file 0001564590-15-003950.txt   7685694

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT atra-20150331.xml EX-101.INS 1164630
9 XBRL TAXONOMY EXTENSION SCHEMA atra-20150331.xsd EX-101.SCH 29844
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20150331_cal.xml EX-101.CAL 34244
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20150331_def.xml EX-101.DEF 130258
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20150331_lab.xml EX-101.LAB 282898
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20150331_pre.xml EX-101.PRE 214789
Mailing Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005 415-287-2410
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 15851730
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences